Conflicting results have been published on whether or not myelodysplastic syndromes (MDS) affect all cell lineages. Involvement of myeloid and erythroid cell lineages has been regularly observed, but it remains controversial whether the different lymphoid cell lineages are involved. In this study of eight patients with MDS associated with monosomy 7, fluorescent in situ hybridization (FISH) was used t o enumerate the chromosomes 7 in interphase cells. With the probe D721, the rate of false-positive detection of monosomy 7 was 3% 2 2% in normal cells. T-and 6-cell lines were established from eight patients with MDS and monosomy 7. As determined by FISH in interphase cells, 1.9% (0% t o 3%) of the cells in the B-cell lines showed one fluorescent spot and 1.1% (OYo t o 2.9%) of the cells in the T-cell lines. These values do not differ from normal values. However, the possibility that normal cells were selected when the T-and B-cell lines were established could not be excluded. Therefore, peripheral blood cells were obtained, separated according t o surface markers specific for lymphoid and myeloid cell lineage with a YELODYSPLASTIC syndromes (MDS) comprise a M group of hematologic disorders characterized by ineffective hematopoiesis resulting in progressive cytopenia affecting erythroid, myeloid, and megakaryocytic lineages. Eventually, 30% to 40% of the patients with MDS will develop acute myeloid leukemia, while others die from complications (hemorrhage, infection) caused by a progressive impairment of hematopoiesis.lJ The need for erythrocyte and platelet transfusions as well as the high susceptibility to infections indicates that multiple cell lineages are involved in the disease.
Conflicting results have been published on whether or not myelodysplastic syndromes (MDS) affect all cell lineages. Involvement of myeloid and erythroid cell lineages has been regularly observed, but it remains controversial whether the different lymphoid cell lineages are involved. In this study of eight patients with MDS associated with monosomy 7, fluorescent in situ hybridization (FISH) was used t o enumerate the chromosomes 7 in interphase cells. With the probe D721, the rate of false-positive detection of monosomy 7 was 3% 2 2% in normal cells. T-and 6-cell lines were established from eight patients with MDS and monosomy 7. As determined by FISH in interphase cells, 1.9% (0% t o 3%) of the cells in the B-cell lines showed one fluorescent spot and 1.1% (OYo t o 2.9%) of the cells in the T-cell lines. These values do not differ from normal values. However, the possibility that normal cells were selected when the T-and B-cell lines were established could not be excluded. Therefore, peripheral blood cells were obtained, separated according t o surface markers specific for lymphoid and myeloid cell lineage with a YELODYSPLASTIC syndromes (MDS) comprise a M group of hematologic disorders characterized by ineffective hematopoiesis resulting in progressive cytopenia affecting erythroid, myeloid, and megakaryocytic lineages. Eventually, 30% to 40% of the patients with MDS will develop acute myeloid leukemia, while others die from complications (hemorrhage, infection) caused by a progressive impairment of hematopoiesis.lJ The need for erythrocyte and platelet transfusions as well as the high susceptibility to infections indicates that multiple cell lineages are involved in the disease.
Several techniques have been applied to document that clonal abnormalities are present in different cell lineages. The first study of glucosed-phosphate dehydrogenase (G-6-PD) isoenzyme patterns demonstrated the origin of peripheral blood lymphocytes to be clonal in a patient with sideroblastic anemia. These lymphocytes displayed the same isoenzyme as the red blood cells (RBCs), granulocytes, and platelets, suggesting that all these lineages were affected by the disease? In another patient with sideroblastic anemia, similar results were seen. Additionally, EpsteinBarr virus (EBV)-transformed B cells were all of the same isotype, suggesting that MDS is a clonal disease derived from pluripotent stem cells. However, the G-6-PD analysis in the latter patient was discordant with karyotypic results; although the marrow cells had specific cytogenetic abnormalities, all B-cell lines showed a normal karyotype:
MDS is a disease associated with multiple chromosomal abnormalities. Deletion of the long arm of chromosome 5 (5q-), monosomy 7, and trisomy 8 are most frequently o b~e r v e d .~,~ The chromosomal abnormalities can be helpful for identifymg which cell lineages are affected, but the results that have been reported have not provided consistent information about which cell lineages are involved in MDS. In two patients with sideroblastic anemia associated with a partial deletion of chromosome 13, as reported by Lawrence et a],' abnormal metaphases were scored in both bone marrow samples and EBV-transformed B-cell lines, while phytohemagglutinin (PHA)-stimulated peripheral blood lymphocytes showed a normal karyotype. Carbonell et a16 have studied lineages affected by the 5q-syndrome in four patients. Cytogenetic analysis of marrow cells showed that three of the four patients had cells with normal karyotypes, cells with trisomy 8, and cells with an interstitial deletion of chromosome 5. Cells from lymphocyte cultures exhibited normal karyotypes in all four cases. Erythroid and myeloid colonies had the 5q deletion in all four patients. However, none of the colonies exhibited trisomy 8.
Results of analyses based on standard cytogenetic techniques may be skewed by the fact that these assays evaluate only the small fraction of cells that are actively dividing or are sensitive to mitogenic stimulation. Two studies that have used the more sensitive technique of restriction fragment length polymorphism (RFLP) to examine DNA polymorphism at X-linked loci have suggested a clonal origin for both myeloid and lymphoid cells in patients with MDS.9,10 Recently, involvement of both lymphoid and myeloid lineages has also been indicated in two patients with MDS examined for mutations in the ras-oncogenes in different cell subpopulations?Jl In contrast with these observations, Kere et all2 reported that five patients with monosomy 7 had two chromosomes 7 in their lymphocytes, but only one chromosome 7 in their granulocytes and monocytes using RFLP analysis of polymorphic sequences on chromosome 7 .
Recently, the technique of fluorescent in situ hybridization (FISH) has been developed. Unlike other techniques, FISH permits enumeration of all nucleated cells for the presence or absence of chromosomal deletions irrespective of cycle status. Because a FISH analysis requires only 500 to 1,000 cells, this technique was considered an excellent tool to study the lineages affected by MDS associated with monosomy 7. We have used the technique of FISH to assess the expression of monosomy 7 in cultured T and B cells as well as in purified T cells, B cells, NK cells, monocytes, granulocytes, and CD33-positive cells from eight patients with MDS and monosomy 7. The results of this study suggest that clonality is usually observed in committed myeloid populations.
MATERIALS AND METHODS
The clinical characteristics of the patients in this report are listed in Table 1 . All patients had a confirmed diagnosis of monosomy 7 by standard cytogenetic techniques. 13 The median age in this group of patients was 8 years, ranging from 1 year to 65 years. The disease in each patient was classified according to the morphologic criteria of the French-American-British (FAB) Cooperative Group.14 At the time of sampling, three patients were diagnosed as having juvenile chronic myelomonocytic leukemia (CMMoL), two patients had refractory anemia, one patient (no. 7) developed secondary MDS 6 years after treatment for Hodglun's disease, and in two patients the disease had converted to acute myeloid leukemia. Patient 1 received two T-cell-depleted bone marrow grafts from an unrelated donor for juvenile chronic myelomonocytic leukemia (Table 1) . Granulocyte-macrophage colony-stimulating factor (GM-CSF) was administered because of persisting low peripheral blood counts after the second transplant. At the time of sampling, the peripheral blood cells consisted mainly of monocytic cells that were mostly expressing monosomy 7. Five patients had chemotherapy before sampling and two patients received supportive care before sampling.
To establish T-cell lines, fresh or cryopreserved peripheral blood mononuclear cells (PBMC) or peripheral blood lymphocytes (PBL) were cultured with irradiated (3,000 rads) third-party PBMC in RPMI-1640 supplemented with penicillin/streptomycin, 15% human serum, 10 kg/mL phytohemagglutinin (PHA-P), and MLA-144 conditioned medium obtained from a gibbon lymphosarcoma cell line as a source of interleukin-2 (IL-2). The resulting cell lines were fed twice weekly, once with the above conditioned medium alone and once with irradiated third-party feeder cells suspended in the conditioned medium.
B-lymphoblastoid cell lines (BLCL) were established by transformation of lymphocytes with EBV using standard techniques. Fresh or cryopreserved PBMC or PBL were suspended in a medium consisting of RPMI-1640 supplemented with penicillin/streptomycin, 15% fetal calf serum (FCS), 25% culture supernatant of the EBV secreting cell line B95-1, and 1 pg/mL PHA for 24 hours. Cells were then transferred to 24-well plates in the same medium minus PHA for the second 24 hours, and fed daily for approximately the next 10 days with RPMI-1640 supplemented with penicillin/streptomycin, 10% FCS. At that time the cells were usually transferred to flasks and maintained with thrice weekly feeding with the medium supplemented with 10% FCS.
PBMC were separated from granulocytes and RBCs by Ficoll-Hypaque (Nycomed Lymphoprep, Accurate Chem. Sci Corp, Westbury, NY) density gradient and stained with directly conjugated antibodies. The Leu-4 (CD3; Becton Dickinson, San Jose, CA), Leu-16 (CD20; Becton Dickinson), leu-20 (CD57; Becton Dickinson), Mol (CDllb; Coulter, Hialeah, FL), My9 (CD33; Coulter) antibodies were used for these studies. After staining, cells were either directly used without fixation or fixed in 0.5% formaldehyde (wt/vol) for 10 minutes. In most cases we avoided fixing cells with fdrmaldehyde because fixation interferes with the hybridization resulting in weak fluorescent signals. Cells were sorted using a FACSTAR PLUS (Becton Dickinson). For the T (CD3), B (CD20), natural killer (NK) (CD57), and monocytes (CDllb; dull fluorescent signal) a window was chosen based on low-side scatter. For granulocytes (brightly fluorescent with Mol/ FITC) and CD33-positive cells no window for scatter was set.
Unfixed cells were sorted directly into an Eppendorf tube filled with methanol/acetic acid. Fixed cells were sorted directly onto slides (HTC coated slides; Cell-line) and the slides were subsequently air dried.
For methanol/acetic acid (vol/ vol 3:l) fixed cells, the procedure of Pinkel et alls was followed as described. Briefly, methanol/acetic acid fixed cells were put onto slides and air dried. Subsequently, slides were put in 2X SSC (1X SSC is 150 mmol/L NaCl, 15 mmol/L sodium citrate) for 10 minutes at room temperature (RT). Denaturation of the doublestranded DNA was achieved by heating the slides in a solution of 70% formamide in 2X SSC (pH 7.4) for 2 minutes at 70°C. Thereafter, the slides were dehydrated by 2-minute exposures to graded ethanol solutions at 4°C. Following this preparation 10 kL T-and B-cell lines.
Sorting.
Fluorescent in situ hybridization.
For personal use only. on November 11, 2017. by guest www.bloodjournal.org From of probe D7Z1 (10 pg/mL biotin-labeled; Oncor, Gaithersburg, MD) and 10 FL salmon sperm DNA (500 mg/mL; Sigma, St Louis, MO) or 10 pL human placenta DNA (500 mg/mL; Sigma) was mixed with 80 pL of a hybridization solution containing 50% formamide/2X SSC/lO% dextran sulphate (final concentration). Ten microliters of this hybridization mixture was put on the slides and covered with a coverslip. Hybridization took place overnight at 37°C. Stringent washing consisted of 3 x 5 minutes in 50% formamide in 2X SSC at 42"C, followed by 3 x 5 minutes in 2X SSC at 42°C. Subsequently, cells were washed for 20 minutes at RT in 1x ssc.
Cells fixed in formaldehyde were treated according to a modified protocol described by Durnam et a1. 16 After storage in 70% ethanol, cells were hydrated in phosphate-buffered saline (PBS), permeabilized in PBS/O.5% Triton, and denaturated at 85°C. The rest of the procedure was identical to the protocol described above.
After the washing in 1X SSC, slides were dipped in a solution containing 4X SSC/O.l% "-40 for 3 minutes followed by 2 x 3 minutes in 4X SSC. The biotinylated probes were detected by applying 20 pL avidin/FITC (5 pg/mL, in 4X SSC/l% bovine serum albumin [BSA]; DCS quality; Vector Laboratories Inc, Burlingame, CA) for 30 minutes. The slides were washed in 4X SSC/O.l% NP-40,4X SSC, and 4X SSC sequentially for 5 minutes each. Amplification of the fluorescence signal was achieved by extra incubation with biotinylated anti-avidin (10 pg/mL; Vector Laboratories Inc) followed by another layer of avidin/FITC. The nuclei were counterstained with propidium iodide (1 to 2 Fg/mL; Sigma) dissolved in antifading s01ution.l~ A Nikon or Zeiss fluorescence microscope were used for visualization. At least 200 cells were scored.
Probe detection.
RESULTS
Expression of monosomy 7 in patient cells, Each patient had documented monosomy 7 by standard cytogenetics. In most cases karyotype analysis was performed on bone marrow samples and in all samples the majority of metaphases showed a deletion of one chromosome 7 ( Table  2 ). The percentage of cells with monosomy 7 ranged from 50% to 100%.
For our study of the lineages affected by MDS, fresh or thawed peripheral blood cells and/or bone marrow cells were examined for the expression of monosomy 7 using FISH analysis. Peripheral blood cells from eight healthy individuals were used as controls. The number of chromosomes 7 were enumerated by counting the number of bright fluorescent spots within a nucleus of a cell. The D7Z1 probe recognizes repetitive sequences on chromosome 7. 18 We used a biotinylated probe and after adding avidin/FITC, relatively weak fluorescent spots were seen within the nuclei. After amplification of the fluorescent signal with anti-avidin and another layer of avidin/FITC, clear visible spots were seen. When salmon sperm DNA was applied as carrier, sometimes multiple spots were seen indicating nonspecific hybridization. Suppression of nonspecific hybridization was achieved by using human placenta DNA instead of salmon sperm DNA.19s20 Using this procedure to suppress nonspecific hybridization, two fluorescent spots were seen in 97% of the cells in control samples. The false-positive rate for the detection of monosomy 7 was 3% with a standard deviation of 2% (N = 8) . The implication of these values is that the diagnosis of monosomy 7 in methanol/acetic acid fixed samples can be made when more than 7% (mean + 2 x standard deviation) of the cells express only one chromosome.
Results of the FISH analyses of patients samples are shown in Fig 1. The expression of monosomy 7 ranged from 26% to 86% in interphase nuclei of peripheral blood mononuclear cells in six patients. A bone marrow aspirate and peripheral blood was taken from patient 5 on the same day. FISH analyses of both samples showed that 26% of the mononuclear cells in peripheral blood expressed monosomy 7 and 50% of the bone marrow cells. Because there were not many cells frozen from patient 5, it was decided to use all peripheral blood cells for establishing T-and B-cell lines and for two sorting experiments. The diagnosis of monosomy 7 was made for patient 5 by standard cytogenetic analysis of a bone marrow aspirate. FISH analysis confirmed the diagnosis of monosomy 7 in a bone marrow sample of patient 6. Bone marrow cells were examined in this patient because all peripheral blood cells had to be used for other experiments. An example of a cell expressing monosomy 7 and a cell with 2 chromosomes 7 is shown in Fig 2A. When looking at the interphase nuclei, granulocytes can be identified based on the size and shape of the nucleus in most patients. In the initial studies it was evident that granulocytes expressed monosomy 7 while cells with a small round nucleus (presumptively lymphocytes) were diploid (Fig 2B) . These observations suggested the possibility that monosomy 7 was not expressed in all cell lineages. Therefore, in subsequent studies, T-and B-cell lines were established and PBMC populations were sorted from each patient to examine the expression of monosomy 7 in cells of different lineages.
When the T-and B-cell lines were established, their immunophenotype was confirmed by immunofluorescence using an anti-CD3 antibody as a marker for T cells and an antLCD20
antibody for B cells. From patient 1, samples were obtained after an allogeneic bone marrow transplantation. The patient did not engraft after two sex-mismatched bone marrow transplants (patient 1; see Table 1 For personal use only. on November 11, 2017. by guest www.bloodjournal.org From that it is important to rule out any contamination of tumor cells when analyzing B-cell lines for the expression of abnormal chromosomes in myelodysplastic patients.
Our analysis of the T-and B-cell lines strongly suggested that the T-and B-cell lineage were not involved in this disease. Nevertheless, we observed one fluorescent spot in some cells. This observation could be explained in several ways. For example, our observations through the fluorescent microscope are two dimensional, while the cell structure is three dimensional. Hence, it is possible for one fluorescent spot in a nucleus to be overlapped by another single fluorescent spot in the same nucleus. It is also possible that cells with one spot actually contain two chromosomes 7 but FISH in certain cases is unable to detect both chromosomes. Alternatively, these cells with one fluorescent spot actually contain one chromosome 7 and are affected by the disease, in which case even if 1% of the cells had only one chromosome 7, the disease could be affecting cells in the T-and B-cell lineages.
We prepared metaphase cells from six T-cell lines and scored the number of chromosomes 7 with the aid of fluorescent probes and standard cytogenetic techniques (Table 4 ). In none of these samples was a deletion of chromosome 7 detected. These results further support our initial contension that the T-cell lines are diploid. Unfortunately, natural selection in favor of diploid cells cannot be ruled out when T-and B-cell lines are established. Therefore, we developed a procedure to study the expression of monosomy 7 in populations of lymphoid and myeloid cells isolated by sorting directly from the blood or marrow. Expression of monosomy 7 in sorted cell populations. For this part of the study we stained cells with monoclonal antibodies, sorted the cells according to their scatter pattern and fluorescence signal, and subsequently used the FISH procedure to visualize the number of chromosomes 7 in the sorted subpopulations. In our initial experiments we compared two different procedures: (1) fixation of the stained cells in 0.5% formaldehyde followed by sorting onto slides and subsequently storing the slides in 70% ethanol; and (2) no fixation with formaldehyde, sorting directly into Eppendorf tubes filled with methanol/acetic acid. Although cell morphology was best maintained when cells were fixed in formaldehyde, FISH analysis was suboptimal and required additional amplification of the fluorescent signal. The best FISH results were seen without the fixation with formaldehyde. The choice of method in our studies depended on the availability of the cell sorter on the same day that we received patient samples. In three control samples the rate of false-positive results ranged from 4.3% to 7.2% with both methods.
After sorting T cells (CD3) obtained from normal controls, 4.8% f 4.4% of the cells had only one fluorescent spot. In our eight patients the expression of monosomy 7 in the T cells did not differ from the control values (Fig 3) . B cells could be purified from five patients. An average of 5.4% of these purified B cells displayed one fluorescent spot in the nucleus (Fig 3) , which is clearly within the normal range (controls: 4% 2 2%). B cells could not be purified by the cell sorter in three of eight patients because in two patients (nos. 1 and 2) no B cells could be detected and in the other patient (no. 5) the number of cells did not allow sorting of all subpopulations. NK cells were purified by selecting cells that expressed the CD57 antigen and had an intermediate forward scatter signal and a low-side scatter signal. In three patients (nos. 2, 4, 8) less than 1% of the peripheral blood cells were NK cells and for one patient (no. 5) not enough cells were available to study NK cells. For the four patients studied, the NK cells expressed one fluorescent spot in a mean of 6.3% of the cells (controls: 5% k 4%). In summary, cells in the lymphoid cell lineage (T, B, and NK cells) in patients with MDS did not differ significantly from the control values in the proportion of cells with a single fluorescent signal, confirming that the lymphoid cell lineage is not involved in MDS associated with monosomy 7.
Three myeloid subpopulations were distinguished according to their expression of the CDllb antigen and the CD33 antigen. The cells with a low expression of the CDllb antigen had a low-side scatter signal and the morphologic features of monocytes. In seven of eight cases we were able to isolate this subpopulation. In contrast to the results in the lymphoid populations, this myeloid subpopulation exhibited monosomy 7 in the majority of patients. In six of seven patients the percentage of cells with monosomy 7 differed significantly from the control values (6% * 2%), ranging from 18% to 78% (Fig 3) . Cells with a high expression of the CDllb antigen usually had a high-side scatter signal and 1 and 8) based on the size and shape of the nuclei. In all the five patients, where we were able to isolate this myeloid subpopulation, the percentage of cells expressing monosomy 7 differed significantly from control values (5% -C 3%; Fig 3) . The majority of the cells (range 61% to 91%) exhibited one fluorescent spot in four of these five patients, and in patient 7 23% of the cells expressed monosomy 7.
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We also distinguished myeloid populations on the basis of expression of the CD33 antigen. The myeloid subpopulation identified by the anti-CD33 antibody contains a variety of cells ranging from mature monocytes to the common progenitor for monocytes and granulocytes. Again, CD33-positive cells from each of the six patients evaluated contained a significant proportion of monosomy 7 cells ranging from 20% to 90% (Fig 3) . These results indicate that cells in the myeloid lineage bear monosomy 7 as a marker of the disease.
DISCUSSION
In this study, we have focused on the expression of monosomy 7 in the lymphoid and myeloid subpopulations.
We used the FISH technique because it is unique in its ability to visualize the chromosomes 7 within a single nucleus using a chromosome-specific probe. In addition, this technique is applicable to all patients and it is not dependent on whether patients show any heterozygosity for Y-linked or autosomal loci. Thirdly, the technique of FISH is sensitive enough to distinguish between subpopulations that do or do not express monosomy 7. In our hands the rate of false positives was 3% f 2% for unseparated cells and 7% f 3% was the highest rate detected in purified subpopulations. Two observations might explain why a higher frequency of false-positive cells was observed after sorting cells: (1) After drying, the size of the cells is smaller after sorting in PBS solution onto slides, which means that the chance of juxtapositioning of the two hybridization regions is higher. When the distance between two signals is not large enough, two signals will be scored as one signal. ( 2) The very bright fluorescent antibodies bound to the cell surface did cause some background. This background staining hampered an accurate scoring. However, the sensitivity was similar to that reported by Anastasi et a12' for the detection of monosomy 9 with a false-positive rate of 7.8% f 1.6%. Nevertheless, despite the higher frequency of false positivity in purified subpopulations, the sensitivity appeared to be good enough to detect significant differences in the proportion of cells expressing monosomy 7 in lymphoid and myeloid subpopulations. deletion. In contrast to these studies and our own study, two other studies about the clonal origin of MDS concluded that the T cells may be affected by MDS. Janssen et a19 used polymerase chain reaction (PCR) to detect point mutations in the Ki-ras and N-ras oncogenes in purified subpopulations. They detected point mutations in T cells from two patients with chronic myelomonocytic le~kemia.~ However, it is possible that contamination could have attributed to these results because the purified T cells contained 5% to 10% contaminating myeloid cells. Tefferi et all0 have reported that T cells from four patients with MDS showed a skewed pattern using RFLP-methylation analysis, suggesting that the T cells were affected by MDS. The reports about the involvement of the B cells in MDS are equivocal. In two patients with a 13q deletion, reported by Lawrence et al,' karyotyping of B-cell lines showed that 3% and 13% of the metaphases had a deletion in the long arm of chromosome 13. In another patient with MDS associated with distinctive chromosomal abnormalities (llq and trisomy B), none of 16 B-cell lines evaluated possessed these abnormal karyotypic features. However, an analysis of the B-cell lines from this same female patient who was heterozygous for the enzyme glucosed-phosphate dehydrogenase (G6PD) showed that 21 of 24 lines were expressing type B G6PD strongly suggesting that the growth of these B cells was at least skewed.8 Our analyses of B-cell lines as well as the B cells (CD20) isolated from the peripheral blood were concordant, and indicated that these B-cell populations are not affected by monosomy 7. A potential source of confusion in studies of lymphoid cell lines from patients with MDS was illustrated in two cases in our series from whom we tried to establish B-cell lines. In these cases only Mol+ tumor cells grew in the cultures. These cells also expressed only one chromosome 7. In both instances the peripheral blood cells of the patients also expressed monosomy 7 in more than 80% of the cells both by karyotyping and FISH. These findings suggest that observations of chromosomal abnormalities in lymphoid lines could, in some instances, be attributable to contamination with diseased monocytic cells expressing monosomy 7.
All studies about the clonal origin of MDS indicate that neutrophils and monocytes are affected by the disease. Our studies of purified myeloid subpopulations also demonstrate that monosomy 7 is predominantly expressed in myeloid cells. Furthermore, our analyses of sorted myeloid populations also show that the cells with monosomy 7 can differentiate into granulocytes and monocytes. Kere et all2 reported identical results. This latter study and our study about the clonal origin of cells with monosomy 7 strongly suggest that MDS associated with monosomy 7 is a disease of committed progenitor cells without the loss of their potential to differentiate into monocytes and granulocytes.
Our study and that of Kere et all2 cannot exclude the possibility that the cells in the lymphoid lineage express monosomy 7, because the techniques used are not sensitive enough to detect the expression of monosomy 7 in less than 3% of the subpopulations. For example, in our study, 98% of the nuclei of the T-cell lines derived from patients with MDS had 2 chromosomes 7 as assessed by FISH analysis, a result which does not differ from that obtained when T cells from normal individuals are evaluated. Because it was desirable to investigate whether the 2% cells did or did not express monosomy 7, metaphases were prepared from the T-cell lines. All metaphases had two chromosomes 7. However, the number of metaphases evaluated was again not sufficient to exclude the possibility that 1% of the cells express monosomy 7. At least 300 metaphases have to be analyzed to accept with 95% confidence limit that 0% of the metaphases do not express monosomy 7." Alternative approaches, such as RFLP or probes for distinctive mutations on chromosome 7, could be proposed to address this issue. However, these techniques may also yield ambiguous results because they cannot distinguish between lymphoid cells and cells contaminating the sorted cell fractions.
Our patient population with MDS is rather young with a median age of 8 years, while the majority of the patients with MDS are over 60 years old? One study has suggested that there are two different forms of acute nonlymphocytic leukemia. Leukemias mainly involving the granulocytic cell lineage, in which normal early progenitor cells were identified, have been reported in children and young adults. In contrast, older patients have another type of acute nonlymphocytic leukemia in which clonal features are detected in early progenitors of all lineagesu Because we performed our studies in a relatively young group of patients, the possibility exists that a different pattern of lineage involvement might be in a group of older patients. However, the one patient over 60 years old who was included in our study showed no involvement of the lymphoid lineage, which is in accordance with our observations in younger patients.
This study about the clonality of MDS associated with monosomy 7 shows that monosomy 7 affects predominantly the myeloid cell lineages. Evaluations of T-and B-cell lines as well as purified lymphoid subpopulations strongly suggest that the lymphoid cells are not expressing monosomy 7.
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